Autonomix Medical, Inc.

NASDAQ: AMIX · Healthcare · Medical - Devices

PublicHQ The Woodlands, TX · MontgomeryCIK 0001617867Reports USD

#1161 of 1,418 Healthcare companies by revenue

EA Score

28D

FH 29DQ 27GM —SS 24

v0.1 · 55/100 weight · provisional

↑ balance-sheet leverage, filing timeliness · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$16.7M

Employees

as of 2026-08-24

Market cap

$2.9M

as of 2026-08-24

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02026

Net income-$16.7M-$16.7M2026

Operating income-$17.0M-$17.0M2026

Total assets$7.6M$7.6M2026

Liabilities$1.7M$1.7M2026

Equity$5.9M$5.9M2026

Revenue trend

FY2024 – FY2026 · USD

FY24

FY25

FY26

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Autonomix Medical, Inc.’s revenue?

Autonomix Medical, Inc. booked $0 in FY2026 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Elixxer Ltd.14D Moleculin Biotech, Inc.42D Medican Enterprises, Inc.——Eco-Growth Strategies Inc.——Indo Global Exchange(s) PTE, Ltd.——BioVaxys Technology Corp.——

Neighbors

Montgomery →

Western Midstream Partners, LP$3.8B75B+Sterling Infrastructure, Inc.$2.5B80B+Kodiak Gas Services, Inc.$1.3B59C Excelerate Energy, Inc.$1.2B52D Howard Hughes Holdings Inc.——Huntsman Corporation$5.7B65B

Key facts

CEOBradley A. Hauser

SectorHealthcare

IndustryMedical - Devices

HeadquartersThe Woodlands, TX

ExchangeNASDAQ: AMIX

Employees10

IPO date2024-01-29

Latest filings

8-K2026-08-26 10-Q2026-08-13 8-K2026-07-28 8-K2026-07-15 8-K2026-07-10 8-K2026-06-24 10-K2026-05-27 10-Q2026-02-11

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.